NAUT

Nautilus Biotechnology, Inc. NAUT

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$190.0K

Quarter to Jun 30

Net income

$-14.47M

Quarter to Jun 30

Free cash flow

$-14.18M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$93.71M total
PERCEPTIVE ADVISORS LLC
$21.76M-7.6%
a16z Capital Management, L.L.C.
$16.95M-48.7%
Cercano Management LLC
$13.41M0.0%
BlackRock, Inc.
$5.03M+1331.9%
VANGUARD CAPITAL MANAGEMENT LLC
$4.77M+0.2%
Comprehensive Financial Management LLC
$4.13M0.0%
CITADEL ADVISORS LLC
$3.55MNew
GEODE CAPITAL MANAGEMENT, LLC
$2.37M+109.7%
ACADIAN ASSET MANAGEMENT LLC
$1.97M+42.4%
Clearstead Advisors, LLC
$1.67M-61.7%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$1.67MNew
SENTINEL TRUST CO LBA
$1.40M0.0%
BARCLAYS PLC
$1.36M+889.2%
RENAISSANCE TECHNOLOGIES LLC
$1.29M+159.9%
JPMORGAN CHASE & CO
$1.10MNew
STATE STREET CORP
$1.05M+158.7%
DIMENSIONAL FUND ADVISORS LP
$889.3K+44.6%
NORTHERN TRUST CORP
$712.9K+256.3%
HRT FINANCIAL LP
$675.0K+453.3%
VANGUARD FIDUCIARY TRUST CO
$660.3K+15.6%
VANGUARD PORTFOLIO MANAGEMENT LLC
$631.6KNew
MARSHALL WACE, LLP
$496.6K-17.0%
Qube Research & Technologies Ltd
$481.2K+223.2%
GOLDMAN SACHS GROUP INC
$472.6K-35.3%
HILLMAN CO
$374.0K0.0%
See all 93 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/NAUT

Earnings Per Share

13fpro.ai/company/NAUT

Loading ratio trend…

NAUT insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Nautilus Biotechnology, Inc. (NAUT): stock profile, AI score and financials

Nautilus Biotechnology, Inc. (NAUT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. NAUT is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q2 2026), Nautilus Biotechnology, Inc. reports quarterly revenue of $190.0K, net income of $-14.5M, free cash flow of $-14.2M. Top institutional holders of NAUT by reported 13-F value include PERCEPTIVE ADVISORS, a16z Capital Management, L.L.C., Cercano Management, based on the most recent SEC filings. NAUT trades on the Nasdaq exchange and files with the SEC under CIK 1808805. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NAUT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Nautilus Biotechnology, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1808805 →